Form 13-F position report

AVITA MEDICAL INC COM

Reported by MILLENNIUM MANAGEMENT LLC

RCEL CUSIP 05380C102 Manager CIK 0001273087

First reported at 267,163 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q2 2022
Shares 267,163 Quarter-end amount reported
Reported value $1,269,000 Fair value at quarter end
Consecutive quarters held 1 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 181000
2021-12-31 0
2022-06-30 1269000
2022-09-30 950000
2022-12-31 2054000
2023-03-31 4687000
2023-06-30 4662390
2023-09-30 297299
2023-12-31 0
2024-12-31 426227
2025-03-31 97558
2025-06-30 1953026
2025-09-30 678143
2025-12-31 132818
2026-03-31 0
2026-06-30 63722

Quarterly position history

How this manager's reported quarter-end position changed over time.

16 quarters
Quarterly reported position history for AVITA MEDICAL INC COM held by MILLENNIUM MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 New 15,429 +15,429 (0.0%) < 0.01% $63,722 2026-08-14
Q1 2026 Reduced 0 -38,498 (-100.0%) 0 $0 2026-05-15
Q4 2025 Reduced 38,498 -94,211 (-71.0%) < 0.01% $132,818 2026-02-17
Q3 2025 Reduced 132,709 -236,483 (-64.1%) < 0.01% $678,143 2025-11-14
Q2 2025 Added 369,192 +357,207 (2980.5%) < 0.01% $1,953,026 2025-08-14
Q1 2025 Reduced 11,985 -21,314 (-64.0%) < 0.01% $97,558 2025-05-15
Q4 2024 New 33,299 +33,299 (0.0%) < 0.01% $426,227 2025-02-14
Q4 2023 Reduced 0 -20,349 (-100.0%) 0 $0 2024-02-14
Q3 2023 Reduced 20,349 -253,748 (-92.6%) < 0.01% $297,299 2023-11-14
Q2 2023 Reduced 274,097 -61,379 (-18.3%) < 0.01% $4,662,390 2023-08-14
Q1 2023 Added 335,476 +24,315 (7.8%) < 0.01% $4,687,000 2023-05-15
Q4 2022 Added 311,161 +130,919 (72.6%) < 0.01% $2,054,000 2023-02-14
Q3 2022 Reduced 180,242 -86,921 (-32.5%) < 0.01% $950,000 2022-11-14
Q2 2022 New 267,163 +267,163 (0.0%) < 0.01% $1,269,000 2022-08-15
Q4 2021 Reduced 0 -10,237 (-100.0%) 0 $0 2022-02-14
Q3 2021 New 10,237 +10,237 (0.0%) < 0.01% $181,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

75 managers reported AVITA MEDICAL INC COM for Q2 2022.

Managers reporting AVITA MEDICAL INC COM in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Reduced 1,147,755 -129,222 < 0.01% $5,452,000 8 qtrs
PURA VIDA INVESTMENTS LLC Added 741,875 +67,559 0.2% $3,524,000 6 qtrs
FARALLON CAPITAL MANAGEMENT LLC Reduced 580,000 -220,000 0.01% $2,755,000 6 qtrs
BlackRock Inc Reduced 476,890 -1,090,740 < 0.01% $2,265,000 8 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 327,280 +112,000 < 0.01% $1,555,000 2 qtrs
MILLENNIUM MANAGEMENT LLC This report New 267,163 +267,163 < 0.01% $1,269,000 1 qtr
GEODE CAPITAL MANAGEMENT LLC Reduced 250,307 -194,399 < 0.01% $1,188,000 8 qtrs
AMERIPRISE FINANCIAL INC Added 153,757 +42,045 < 0.01% $730,000 2 qtrs
RTW INVESTMENTS LP Unchanged 106,667 0 0.01% $507,000 6 qtrs
Ergoteles LLC New 101,963 +101,963 0.01% $484,000 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
267,163
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.